WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018023126) METHODS OF TREATING OSMIDROSIS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/023126    International Application No.:    PCT/US2017/044731
Publication Date: 01.02.2018 International Filing Date: 31.07.2017
IPC:
C12N 15/09 (2006.01), C12N 15/113 (2010.01), A61Q 15/00 (2006.01), A61K 9/06 (2006.01), A61K 31/7088 (2006.01), A61P 17/00 (2006.01)
Applicants: KASPAR, Roger L. [US/US]; (US).
BARKER, Thomas V. [US/US]; (US)
Inventors: KASPAR, Roger L.; (US).
BARKER, Thomas V.; (US)
Agent: OSBORNE, David W.; (US)
Priority Data:
62/368,896 29.07.2016 US
Title (EN) METHODS OF TREATING OSMIDROSIS
(FR) PROCÉDÉS DE TRAITEMENT DE L'OSMIDROSE
Abstract: front page image
(EN)A method of treating an osmidrosis condition in a subject can include administering a therapeutic agent in an amount that is effective to inhibit expression of an ABCC11 gene in a target cell of the subject to an osmidrosis-reducing level. A therapeutic composition for treating an osmidrosis condition in a subject can include a therapeutically effective amount of an ABCC11 gene-inhibiting agent and a pharmaceutically acceptable carrier.
(FR)L'invention concerne un procédé de traitement d'une affection d'osmidrose chez un sujet qui peut comprendre l'administration d'un agent thérapeutique en une quantité qui est efficace pour inhiber l'expression d'un gène ABCC11 dans une cellule cible du sujet à un niveau réduisant l'osmidrose. L'invention concerne une composition thérapeutique pour traiter une affection d'osmidrose chez un sujet qui peut comprendre une quantité thérapeutiquement efficace d'un agent inhibiteur du gène ABCC11 et d'un véhicule pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)